The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the double-blind segment is to compare effects of alagebrium vs
placebo on change from baseline in endothelial function, as assessed by flow-mediated
vasodilation (FMD).
Phase:
Phase 2
Details
Lead Sponsor:
Synvista Therapeutics, Inc
Collaborators:
National Heart and Lung Institute National Institutes of Health (NIH)